We use cookies for a better user experience. Read our Privacy Policy
I Agree
Point-of-Care Glucose Testing Market
Newly-released Point-of-Care Glucose Testing Market analysis report by Transparency Market Research reveals that global sales of Point-of-Care Glucose Testing in 2021 were held at US$ 3.7 Bn. With a CAGR of 4.3% during 2022 - 2032, the market is projected to reach a valuation of US$ 5.8 Bn by 2032.
Accu-Chek Inform II product type is expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 5.1% during 2022 – 2032. The market is projected to witness an absolute dollar growth of US$ 2 Bn.
As per the Point-of-Care Glucose Testing Market research by Transparency Market Research - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Market increased at around 3.5% CAGR.
The key drivers that will impact the market include the surge in the geriatric population, the instant and timely results that point-of-care (POC) screening can provide, and the increased usage of Electronic Medical Records (EMRs).
Skilled personnel are not adequate enough which necessitates the adoption of glucose POC diagnostics. Diabetes increasing the risk of COVID-19-related mortality is another key factor boosting market growth.
According to Transparency Market Research, Market revenue would increase 1.5X between 2022 and 2032, reaching roughly US$ 5.8 Bn by 2032.
The increasing number of diabetes patients as well as technological advancements and increased awareness about the usage of point-of-care glucose testing are contributing to the market's growth. As there is a rise in needle-free blood glucose monitoring devices, several key players are offering painless diabetes care to patients.
Clinical & Laboratories Standard Institute, an International Organization recently regulated the guideline for accuracy in point-of-care glucose testing for standardization. In the critical care unit, the POCT gadget is widely employed. In recent years, there has been a rise in the need for POC testing.
Diabetes control has been the highest priority of healthcare professionals which can help to reduce the death rate. Diabetes Research Foundation mentions that diabetes will decrease the life expectancy in COVID-19 patients by 50%.
Growing diabetes awareness, limited healthcare facilities, and less number of healthcare professionals in Asian nations will drive the point-of-care glucose testing systems market. As a result, there is an opportunity to save money on healthcare while also improving the quality of care.
One of the key factors that are restricting the market's growth is a lack of understanding of the test. The test accuracy is another stumbling block to market expansion.
There are a lot of false detection tests that are discovered. Despite the fact that these tests were developed after substantial research and development, they are nevertheless susceptible to misdiagnosis.
North America held the largest market in 2021, contributing for even more than 40% of overall global sales. Several major market participants, including Abbott, Nova Biomedical, and Prodigy Diabetes Care, LLC, are based in this region. As a result, the diabetes testing products are easily accessible and available so they expanded in less timeframe, contributing to boosting the regional market's revenue.
Furthermore, the government has increased spending on healthcare, especially on diabetes, which is one of the factors driving the regional market growth.
POC tests are in high demand due to their benefits, including quick, simple, portable diagnosis and self-monitoring. These devices serve patients in hospitals, medical screenings, clinics, and homes, as well as making diagnosis and monitoring easier.
Constantly expanding healthcare infrastructure and an elevated risk of diabetes are projected to drive the market in the Asia Pacific. An increase in the deployment of smaller variants, as well as the hesitation or avoidance of hospital and clinic appointments, is boosting the demand.
POC glucose diagnostics is projected to grow more commonly in ORs, emergency rooms, Critical Care Units, diagnostic labs, and hospitals because of their speedy and accurate results.
The market in the U.S. is projected to reach a valuation of US$ 2.1 Bn by 2032. Growing at a CAGR of 4.5% during 2022 – 2032, the market in the country is expected to gross an absolute dollar opportunity of US$ 732 Mn.
The market in the country is expected to reach US$ 222 Mn by 2032. During the forecast period, the market in the country is expected to garner an absolute dollar opportunity of around US$ 70 Mn during 2022 - 2032.
Accu-Check Inform II accounted for more than 54% of worldwide revenue in 2021 and further it is expected to grow consistently over the forecast period. A POC monitor device allows the patients to self-monitor their blood glucose level at home which helps them to perform normal activities easily.
Also, these devices are now used in inpatient settings since they are simple to use and provide fast results.
On the other hand over the projected period, the FreeStyle Lite product category is expected to increase at the fastest rate. Abbott offers the FreeStyle Lite, which comes in a small package with a built-in portlight and backlight, making it convenient for patients who have a busy schedule.
Blood sugar levels are measured using samples taken from the hand, upper limbs, fingers, forearm, and thigh. The FreeStyle Lite meter should only be used with the FreeStyle control solution and testing strips, as using other monitoring tools and test strips may result in wrong results.
Professional diagnostic centers, hospitals & clinics, home care settings, and Research labs are among the key end-users in the global market. The home care settings segment dominated the global market.
During the forecast period, the market through this segment is expected to increase at the fastest rate. The rise in acceptance of home health care, technological developments and cost-effectiveness to other traditional treatments is contributing to an increase in demand for home care settings.
Some of the major key players featured in the report are F. Hoffmann-La Roche, Nova Biomedical, Nipro, Platinum Equity Advisors, ACON Laboratories, Trividia Health, Prodigy Diabetes Care, Bayer AG/Ascensia Diabetes Care Holdings AG, Abbott and EKF Diagnostics.
Some of the recent developments of Market key providers are as follows:
By Product Type
By End User
By Region
|
Attribute |
Details |
|
Global Market (2022) |
US$ 3.8 Bn |
|
Global Market (2032) |
US$ 5.8 Bn |
|
Global Market CAGR (2022 – 2032) |
4.3% |
|
U.S. Market CAGR (2022 – 2032) |
4.5% |
|
Key Companies Profiled |
|
The market is worth more than US$ 3.7 Bn at present.
The market value is projected to increase at a CAGR of around 4.3% during 2022 – 2032.
The market value increased at a CAGR of around 3.5% during 2017 – 2021.
There is a rise in the frequency of diabetic patients, which is expected to shape the demand for point-of-care glucose testing globally.
The market in China is projected to expand at a CAGR of around 4.6% during 2022 – 2032.
While the market in South Korea is expected to grow at nearly 5.7%, the market in Japan is projected to register a CAGR of nearly 5.3% during 2022 - 2032.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
4. Global Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032
5.3.1. Freestyle Lite
5.3.2. Accu-Chek Inform II
5.3.3. StatStrip
5.3.4. Onetouch Verio Flex
5.3.5. Accu Check Aviva Meter
5.3.6. True Metrix
5.3.7. Bayer CONTOUR Blood Glucose Monitoring System
5.3.8. i-STAT
5.3.9. Other Product Type
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032
6. Global Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
6.3.1. Professional Diagnostic Centres
6.3.2. Hospital and Clinics
6.3.3. Home care settings
6.3.4. Research Lab
6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
6.5. Absolute $ Opportunity Analysis By End User, 2022-2032
7. Global Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. East Asia
7.3.5. South Asia
7.3.6. Oceania
7.3.7. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Product Type
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Argentina
9.2.1.4. Rest of Latin America
9.2.2. By Product Type
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By End User
9.4. Key Takeaways
10. Europe Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. Italy
10.2.1.3. France
10.2.1.4. U.K.
10.2.1.5. Spain
10.2.1.6. Russia
10.2.1.7. BENELUX
10.2.1.8. Rest of Europe
10.2.2. By Product Type
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By End User
10.4. Key Takeaways
11. East Asia Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.2. By Product Type
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By End User
11.4. Key Takeaways
12. South Asia Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Thailand
12.2.1.3. Malaysia
12.2.1.4. Indonesia
12.2.1.5. Rest of South Asia
12.2.2. By Product Type
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By End User
12.4. Key Takeaways
13. Oceania Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. Australia
13.2.1.2. New Zealand
13.2.2. By Product Type
13.2.3. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By End User
13.4. Key Takeaways
14. MEA Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. GCC
14.2.1.2. Rest of MEA
14.2.2. By Product Type
14.2.3. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By End User
14.4. Key Takeaways
15. Key Countries Point-of-Care Glucose Testing Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Product Type
15.1.2.2. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Product Type
15.2.2.2. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Product Type
15.3.2.2. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Product Type
15.4.2.2. By End User
15.5. Argentina
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Product Type
15.5.2.2. By End User
15.6. Germany
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Product Type
15.6.2.2. By End User
15.7. Italy
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Product Type
15.7.2.2. By End User
15.8. France
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Product Type
15.8.2.2. By End User
15.9. U.K.
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Product Type
15.9.2.2. By End User
15.10. Spain
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Product Type
15.10.2.2. By End User
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Product Type
15.11.2.2. By End User
15.12. BENELUX
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Product Type
15.12.2.2. By End User
15.13. China
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Product Type
15.13.2.2. By End User
15.14. Japan
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Product Type
15.14.2.2. By End User
15.15. South Korea
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Product Type
15.15.2.2. By End User
15.16. India
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Product Type
15.16.2.2. By End User
15.17. Thailand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Product Type
15.17.2.2. By End User
15.18. Malaysia
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Product Type
15.18.2.2. By End User
15.19. Indonesia
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Product Type
15.19.2.2. By End User
15.20. Australia
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2021
15.20.2.1. By Product Type
15.20.2.2. By End User
15.21. New Zealand
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2021
15.21.2.1. By Product Type
15.21.2.2. By End User
15.22. GCC Countries
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2021
15.22.2.1. By Product Type
15.22.2.2. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product Type
16.3.3. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. F. Hoffmann-La Roche Ltd.
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Abbott
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Nipro
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. PlatInium Equity Advisors
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Nova Biomedical
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. ACON Laboratories
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Trividia Health
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Prodigy Diabetes Care
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Bayer AG/Ascensia Diabetes Care Holdings AG
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. EKF Diagnostics
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
List of Tables
Table 1: Global Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 3: Global Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 4: North America Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 5: North America Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 6: North America Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 7: Latin America Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 8: Latin America Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 9: Latin America Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 10: Europe Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 11: Europe Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 12: Europe Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 13: East Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: East Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 15: East Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 16: South Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 17: South Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 18: South Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 19: Oceania Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 20: Oceania Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 21: Oceania Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 22: MEA Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 23: MEA Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 24: MEA Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032
List of Figure
Figure 1: Global Point-of-Care Glucose Testing Market Value (US$ Mn) by Product Type, 2022-2032
Figure 2: Global Point-of-Care Glucose Testing Market Value (US$ Mn) by End User, 2022-2032
Figure 3: Global Point-of-Care Glucose Testing Market Value (US$ Mn) by Region, 2022-2032
Figure 4: Global Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 5: Global Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 6: Global Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 7: Global Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 8: Global Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 9: Global Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 10: Global Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 11: Global Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 12: Global Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 13: Global Point-of-Care Glucose Testing Market Attractiveness by Product Type, 2022-2032
Figure 14: Global Point-of-Care Glucose Testing Market Attractiveness by End User, 2022-2032
Figure 15: Global Point-of-Care Glucose Testing Market Attractiveness by Region, 2022-2032
Figure 16: North America Point-of-Care Glucose Testing Market Value (US$ Mn) by Product Type, 2022-2032
Figure 17: North America Point-of-Care Glucose Testing Market Value (US$ Mn) by End User, 2022-2032
Figure 18: North America Point-of-Care Glucose Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 19: North America Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 20: North America Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 21: North America Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 22: North America Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 23: North America Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 24: North America Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 25: North America Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 26: North America Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 27: North America Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 28: North America Point-of-Care Glucose Testing Market Attractiveness by Product Type, 2022-2032
Figure 29: North America Point-of-Care Glucose Testing Market Attractiveness by End User, 2022-2032
Figure 30: North America Point-of-Care Glucose Testing Market Attractiveness by Country, 2022-2032
Figure 31: Latin America Point-of-Care Glucose Testing Market Value (US$ Mn) by Product Type, 2022-2032
Figure 32: Latin America Point-of-Care Glucose Testing Market Value (US$ Mn) by End User, 2022-2032
Figure 33: Latin America Point-of-Care Glucose Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 34: Latin America Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 35: Latin America Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 36: Latin America Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 37: Latin America Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 38: Latin America Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 39: Latin America Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 40: Latin America Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 41: Latin America Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 42: Latin America Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 43: Latin America Point-of-Care Glucose Testing Market Attractiveness by Product Type, 2022-2032
Figure 44: Latin America Point-of-Care Glucose Testing Market Attractiveness by End User, 2022-2032
Figure 45: Latin America Point-of-Care Glucose Testing Market Attractiveness by Country, 2022-2032
Figure 46: Europe Point-of-Care Glucose Testing Market Value (US$ Mn) by Product Type, 2022-2032
Figure 47: Europe Point-of-Care Glucose Testing Market Value (US$ Mn) by End User, 2022-2032
Figure 48: Europe Point-of-Care Glucose Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 49: Europe Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 50: Europe Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 51: Europe Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 52: Europe Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 53: Europe Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 54: Europe Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 55: Europe Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 56: Europe Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 57: Europe Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 58: Europe Point-of-Care Glucose Testing Market Attractiveness by Product Type, 2022-2032
Figure 59: Europe Point-of-Care Glucose Testing Market Attractiveness by End User, 2022-2032
Figure 60: Europe Point-of-Care Glucose Testing Market Attractiveness by Country, 2022-2032
Figure 61: East Asia Point-of-Care Glucose Testing Market Value (US$ Mn) by Product Type, 2022-2032
Figure 62: East Asia Point-of-Care Glucose Testing Market Value (US$ Mn) by End User, 2022-2032
Figure 63: East Asia Point-of-Care Glucose Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 64: East Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 65: East Asia Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 66: East Asia Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 67: East Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 68: East Asia Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 69: East Asia Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 70: East Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 71: East Asia Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 72: East Asia Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 73: East Asia Point-of-Care Glucose Testing Market Attractiveness by Product Type, 2022-2032
Figure 74: East Asia Point-of-Care Glucose Testing Market Attractiveness by End User, 2022-2032
Figure 75: East Asia Point-of-Care Glucose Testing Market Attractiveness by Country, 2022-2032
Figure 76: South Asia Point-of-Care Glucose Testing Market Value (US$ Mn) by Product Type, 2022-2032
Figure 77: South Asia Point-of-Care Glucose Testing Market Value (US$ Mn) by End User, 2022-2032
Figure 78: South Asia Point-of-Care Glucose Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 79: South Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 80: South Asia Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 81: South Asia Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 82: South Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 83: South Asia Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 84: South Asia Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 85: South Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 86: South Asia Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 87: South Asia Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 88: South Asia Point-of-Care Glucose Testing Market Attractiveness by Product Type, 2022-2032
Figure 89: South Asia Point-of-Care Glucose Testing Market Attractiveness by End User, 2022-2032
Figure 90: South Asia Point-of-Care Glucose Testing Market Attractiveness by Country, 2022-2032
Figure 91: Oceania Point-of-Care Glucose Testing Market Value (US$ Mn) by Product Type, 2022-2032
Figure 92: Oceania Point-of-Care Glucose Testing Market Value (US$ Mn) by End User, 2022-2032
Figure 93: Oceania Point-of-Care Glucose Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 94: Oceania Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 95: Oceania Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 96: Oceania Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 97: Oceania Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 98: Oceania Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 99: Oceania Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 100: Oceania Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 101: Oceania Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 102: Oceania Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 103: Oceania Point-of-Care Glucose Testing Market Attractiveness by Product Type, 2022-2032
Figure 104: Oceania Point-of-Care Glucose Testing Market Attractiveness by End User, 2022-2032
Figure 105: Oceania Point-of-Care Glucose Testing Market Attractiveness by Country, 2022-2032
Figure 106: MEA Point-of-Care Glucose Testing Market Value (US$ Mn) by Product Type, 2022-2032
Figure 107: MEA Point-of-Care Glucose Testing Market Value (US$ Mn) by End User, 2022-2032
Figure 108: MEA Point-of-Care Glucose Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 109: MEA Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 110: MEA Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 111: MEA Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 112: MEA Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 113: MEA Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 114: MEA Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 115: MEA Point-of-Care Glucose Testing Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 116: MEA Point-of-Care Glucose Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 117: MEA Point-of-Care Glucose Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 118: MEA Point-of-Care Glucose Testing Market Attractiveness by Product Type, 2022-2032
Figure 119: MEA Point-of-Care Glucose Testing Market Attractiveness by End User, 2022-2032
Figure 120: MEA Point-of-Care Glucose Testing Market Attractiveness by Country, 2022-2032
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes